Literature DB >> 18992395

Global health-care implications of substandard medicines.

Kathryn Senior.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18992395     DOI： 10.1016/S1473-3099(08)70241-X

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  5 in total

1.  Impact of poor-quality medicines in the 'developing' world.

Authors:  Paul N Newton; Michael D Green; Facundo M Fernández
Journal:  Trends Pharmacol Sci       Date:  2010-02-01       Impact factor: 14.819

2.  Cross-sectional study of availability and pharmaceutical quality of antibiotics requested with or without prescription (Over The Counter) in Surabaya, Indonesia.

Authors:  Usman Hadi; Peterhans van den Broek; Erni P Kolopaking; Nun Zairina; Widjoseno Gardjito; Inge C Gyssens
Journal:  BMC Infect Dis       Date:  2010-07-09       Impact factor: 3.090

3.  A poor-quality generic drug for the treatment of visceral leishmaniasis: a case report and appeal.

Authors:  Thomas P C Dorlo; Teunis A Eggelte; Gerard J Schoone; Peter J de Vries; Jos H Beijnen
Journal:  PLoS Negl Trop Dis       Date:  2012-05-29

4.  Chemical and bioassay techniques to authenticate quality of the anti-leishmanial drug miltefosine.

Authors:  Harparkash Kaur; Karin Seifert; Geoffrey E Hawkes; Gregory S Coumbarides; Jorge Alvar; Simon L Croft
Journal:  Am J Trop Med Hyg       Date:  2015-04-20       Impact factor: 2.345

5.  Quality of medicines: Deficiencies found by Brazilian Health Regulatory Agency (ANVISA) on good manufacturing practices international inspections.

Authors:  Andrea Renata Cornelio Geyer; Varley Dias Sousa; Dâmaris Silveira
Journal:  PLoS One       Date:  2018-08-08       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.